Proteins implicated in Alzheimer disease: The role of FE65, a new adapter which binds to β-amyloid precursor protein

Advances in Experimental Medicine and Biology

Volumn 446, Issue , 1998, Pages 161-180

  Ermekova, K S ^a   Chang, A ^a   Zambrano, N ^a   De Candia, P ^a   Russo, T ^a   Sudol, M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; PROTEIN FE65; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CONFERENCE PAPER; GENE MUTATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 0032223777     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4869-0_10     Document Type: Conference Paper

References (120)

1. Amyloid β-protein and the genetics of Alzheimer's disease
2. Alzheimer's disease: Genotypes, phenotypes and treatments
3. Mechanisms of neuronal degeneration in Alzheimer's disease
4. Making models for Alzheimer's disease
5. Alternative conformations of amiloidogenic proteins govern their behavior
6. Normal and abnormal biology of the β-amyloid precursor protein
7. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
8. β-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues
9. The Alzheimer amyloid precursor protein
10. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
11. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
12. Signal-dependent membrane protein trafficking in the endocytic pathway
13. The amyloid β-protein precursor and its mammalian homologs
14. Isolation and characterization of APLP2 encoding a homologue of the Alzhelmer's associated amyloid β protein precursor
15. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid β protein precursor
16. Selective localization of amyloid precursor-like protein I in the cerebral cortex postsynaptic density
17. Cleavage of amyloid β peptide during constitutive processing of its precursor
18. Production of the Alzheimer amyloid β protein by normal proteolytic processing
19. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells
20. Evidence that production and release of amyloid β-protein involves the endocytic pathway
21. Amyloid β-peptide is produced by cultured cells during normal metabolism
22. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains
23. βamyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease
24. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing
25. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
26. Metabolism of Alzheimer β-amyloid precursor protein: Regulation by protein kinase A in intact cells and in a cell-free system
27. Release of excess amyloid β protein from a mutant amyloid β protein precursor
28. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
29. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein
30. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype
31. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
32. Amyloid β peptide formation in cell-free preparations
33. Generation of amyloid β protein from its precursor is sequence specific
34. Presenilins and Alzheimer disease
35. The presenilin genes: A new gene family involved in Alzheimer disease pathology
36. Protein topology of presenilin 1
37. Membrane topology of the C. elegans SEL-12 presenilin
38. In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain
39. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues
40. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families
41. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease
42. Molecular analysis of the presenilin 1 (S182) gene in "sporadic" cases of Alzheimer's disease: Identification and characterization of unusual splice variants
43. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
44. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta 1-42/1-40 ratio in vitro and in vivo
45. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1
46. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology
47. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
48. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effects of ALG-3
49. Structure, microtubule interactions, and phosphorylation of Tau protein
50. Domains of Tau protein, differential phosphorylation, and dynamic instability of microtubules
51. Site-specific regulation of Alzheimer-like tau phosphrylation in living neurons
52. Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain
53. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase 1/glycogen synthase kinase 3β in brain
54. βAPP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease
55. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia
56. Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation
57. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample
58. Structure and expression of the rat apolipoprotein E gene
59. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E
60. The baboon apolipoprotein E gene: Structure, expression, and linkage with the gene for apolipoprotein C-1
61. The mouse apolipoprotein C1 gene: Structure and expression
62. Expression of the very low-density lipoprotein receptor (VLDL-r), an Apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease
63. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
64. Isolation of cDNA fragments hybridizing to rat brain-specific mRNAs
65. Expression of the neuron-specific FE65 gene marks the development of embryo ganglionic derivatives
66. The DNA sequence encompassing the transcription start site of a TATA-less promoter contains enough information to drive neuron-specific transcription
67. Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein
68. Interaction of the tandem PID/PTB-related domain of FE65 with wild type and mutant Alzheimer's β-amyloid precursor proteins
69. A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases
70. The regions of the FE65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
71. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain
72. A phosphotyrosine interaction domain
73. Protein modules and signalling networks
74. Characterization of a novel protein-binding module - The WW domain
75. Towards prediction of cognate complexes between the WW domain and proline-rich ligands
76. Structure and function of the WW domain
77. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules
78. Characterization of the WW domain of human Yes-associated protein and its ligands, WBP-1 and WBP-2
79. The WW module competes with the SH3 domain?
80. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains
81. WW domain of Nedd4 bind to the proline-rich PY motifs in the epithelial Na channel deleted in Liddle's syndrome
82. The WW domain: A signalling site in dystrophin?
83. WW domains and retrovirus budding
84. Structure and ligand recognition of the phosphotyrosine binding domain of Shc
85. PTB domains of IRS-1 and She have distinct but overlapping binding specificities
86. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for She phosphorylation by insulin in vivo
87. A region in She distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors
88. She adaptor proteins are key transducers of mitogenic signalling mediated by the G protein-coupled thrombin receptor
89. Identification of residues within the Shc phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction
90. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites
91. The PI domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
92. cDNA cloning and chromosome mapping of the human FE65 gene: Interaction of the conserved cytoplasmic domain of the human β-amyloid precursor protein and its homologues with the mouse FE65 protein
93. The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeats two hybrid system
94. Structure of the WW domain of a kinase-associate protein complexed with a proline-rich peptide
95. Mbh1: A novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo
96. Molecular cloning of human macrophage capping protein cDNA
97. Direct observation of actin filament severing by gelsolin and binding by gCap39 and CapZ
98. Purification and expression of gCap39
99. gCap39, a calcium ion and polyphosphoinositide-regulated actin capping protein
100. gCap39 is phosphorylated
101. gCap39 is a nuclear and cytoplasmic protein
102. Alzheimer amyloid protein precursor forms a complex with brain GTP binding protein Go
103. APP-BPI, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein
104. Ligand-dependent G protein coupling function of amyloid transmembrane precursor
105. Intrinsinc signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimers disease
106. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP
107. Identification of the Alzheimer β/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells
108. Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain
109. Enhanced release of amyloid beta protein from codon 670/671 "Swedish" mutant beta amyloid precursor protein occurs in both secretory and endocytic pathways
110. Direct control of exocytosis by receptor activation of the heterotrimeric GTPases Gi and Go or the expression of their active Gα-subunits
111. Negative trans-activation of cAMP response element by familial Alzheimer's mutants of APP
112. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor
113. Mutation of the beta amyloid precursor protein in familial Alzheimer's disease increases beta protein production
114. The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila Enabled
115. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of Microfilament dynamics
116. The FE65 adaptor protein interacts through its PID1 domain with the transcriptional factor CP2/LSF/LBP1
117. The X11α protein slows cellular amyloid precursor protein processing and reduces Aβ40 and Aβ42 secretion
118. X11 interaction with β-protein secretion
119. The human FE65 gene: Genomic structure and intronic polymorphism associated with sporadic dementia of the Alzheimer type
120. From Src Homology domains to other signaling modules: Proposal of the 'protein recognition code'